Dow Up 0.11% Nasdaq Up 0.50%

Progenics Pharmaceuticals, Inc. (PGNX)

-NasdaqGS
5.51 Up 0.21(3.96%) Aug 29, 4:00PM EDT
|After Hours : 5.55 Up 0.04 (0.73%) Aug 29, 5:02PM EDT
Prev Close:5.30
Open:5.30
Bid:5.24 x 100
Ask:5.80 x 13500
1y Target Est:9.50
Beta:1.41
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:5.27 - 5.52
52wk Range:3.10 - 7.45
Volume:962,662
Avg Vol (3m):1,434,050
Market Cap:383.25M
P/E (ttm):N/A
EPS (ttm):-0.69
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PGNX

Comparison

Symbol% ChgMkt Cap
PGNXUp 3.96%383.25M
DNDN 0.00%211.38M
NKTRDown 0.35%1.82B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):51.72
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.22
Quarterly EPS Est (Sep-14) :-0.15
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-1.00

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Progenics Pharmaceuticals, Inc. develops medicines for oncology. The company offers Relistor-subcutaneous injection for the treatment of opioid induced constipation (OIC) in advanced-illness patients receiving palliative care when laxative therapy... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback